title: Chemotherapy for Bone Sarcoma in Adults.
abstract: The largest studies of chemotherapy for bone sarcomas are in the pediatric population. Although increasing age is often found to be an adverse prognostic factor in these clinical trials, few studies are aimed at assessing regimens specifically in the adult population. Osteosarcoma and Ewing sarcoma have peak incidences in the pediatric and young adult population but also occur in adults. Chondrosarcoma and giant cell tumor of bone are generally found in adults. In this review, we describe the current status of our knowledge about treating adults with cancers of bone origin. We also describe our experience treating patients in the adult Sarcoma Medical Oncology group at The University of Texas MD Anderson Cancer Center.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Wagner
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: J Andrew
authors.initials: JA
authors.lastname: Livingston
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Shreyaskumar R
authors.initials: SR
authors.lastname: Patel
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX rbenjami@mdanderson.org.
authors.forename: Robert S
authors.initials: RS
authors.lastname: Benjamin
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D017024:Chemotherapy, Adjuvant; D006801:Humans; D012516:Osteosarcoma / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality
chemical_list: D000970:Antineoplastic Agents